⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OABI News
OmniAb, Inc. Common Stock
OmniAb to Report Third Quarter 2026 Financial Results on October 30
businesswire.com
OABI
OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company
businesswire.com
OABI
LLY
Form 8-K
sec.gov
OABIW
OABI
VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb
globenewswire.com
VRXA
OABI
Form 8-K
sec.gov
OABI
OABIW
Form 8-K
sec.gov
OABIW
OABI
Form 8-K
sec.gov
OABI
OABIW
OmniAb Reports First Quarter 2026 Financial Results and Business Highlights
businesswire.com
OABI
OmniAb to Participate in Three Upcoming Investor Conferences
businesswire.com
OABI
OmniAb to Report First Quarter 2026 Financial Results on May 7
businesswire.com
OABI